Stem cell blogs are an increasingly important part of the stem cell field. Today in 2013 it is a far different world for stem cell blogs than when I first had my idea to have a blog in 2009 and when I got it going in early 2010. It was pretty darn lonely back then. […]
Stem Cell Blog of the Year 2013: Signals Blog by Stem Cell Network/CCRM Read More »
The 2013 World Stem Cell Summit this past week in San Diego was an amazing experience with so many positives to it. Being the recipient of the National Advocacy Award for stem cells was certainly wonderful and exciting. The fact that Michael J. Fox was a past recipient of this same award blows my mind. To
What the National Advocacy Award for Stem Cells Means to Me Read More »
I just participated in a panel discussion at the World Stem Cell Summit moderated by Lee Buckler on what patients should be thinking about as they contemplate non-compliant stem cell interventions. Also on the panel was Dr. Allan Wu. Both Lee and Al are exceptional members of the stem cell community so it was fantastic
World Stem Cell Summit Panel on Non-Compliant Stem Cells Read More »
I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stem cell biotech stock ticker. The ticker is for some of the most widely held stem and cellular medicine companies. A sample screen shot is shown in this post. Quite a few stem cell-related
New Stem Cell Stock Ticker Read More »
I’m flying out to San Diego today for the World Stem Cell Summit. I’ve been attending this great meeting every year lately and I always return home feeling more informed and energized. Here’s this year’s agenda. At the meeting, I will be doing a book signing tomorrow, Wednesday December 4th, from noon-2pm near the WSCS
Heading to 2013 World Stem Cell Summit Read More »
I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers
Cell Surgical Network Series Part 3: Key Concerns Read More »
The stem cell field has seen quite a few high-profile, intriguing papers on induced pluripotent stem (iPS) cells. Which do you think is the iPS cell paper of the year for 2013? The iPS cell field continues to advance rapidly. If you think one not listed is the best, let us know in the comments.
iPS cell paper of the year 2013: cast your vote Read More »
Today I am posting Part 2 of my interview with Drs. Lander and Berman of the Cell Surgical Network. You can read Part 1 here, which is an interesting look inside the Network. The final portion of this blog post series, Part 3, is my take on their answers and you might not be surprised that
Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use Read More »
The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1,
Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »
A team led by Shinya Yamanaka has published a new study reporting analysis of defective induced pluripotent stem (iPS) cells in the journal PNAS. Part of what I liked so much about this paper is that it tackled a very real, but controversial area of stem cell research. By this I mean the reality that a
Review of New Yamanaka Paper on Defective iPS cells Read More »